{"id":"https://openalex.org/W32933433","doi":null,"title":"IPH-2101, a fully human anti-NK-cell inhibitory receptor mAb for the potential treatment of hematological cancers.","display_name":"IPH-2101, a fully human anti-NK-cell inhibitory receptor mAb for the potential treatment of hematological cancers.","alternate_titles":[],"publication_year":2010,"publication_date":"2010-12-01","ids":{"openalex":"https://openalex.org/W32933433","mag":"32933433","pmid":"https://pubmed.ncbi.nlm.nih.gov/21154164"},"language":"en","primary_location":{"id":"pmid:21154164","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21154164","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current opinion in molecular therapeutics","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W32933433"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5045493438","display_name":"Evren Alici","orcid":"https://orcid.org/0000-0001-5307-6648","observed_orcids":["https://orcid.org/0000-0001-5307-6648"]},"institutions":[{"id":"https://openalex.org/I1335113835","display_name":"Karolinska University Hospital","ror":"https://ror.org/00m8d6786","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I1335113835"]},{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":true,"raw_author_name":"Evren Alici","raw_affiliation_strings":["Karolinska Institutet, Karolinska University Hospital Huddinge, Department of Medicine, SE-14186 Stockholm, Sweden. Evren.Alici@ki.se"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Karolinska Institutet, Karolinska University Hospital Huddinge, Department of Medicine, SE-14186 Stockholm, Sweden. Evren.Alici@ki.se","institution_ids":["https://openalex.org/I1335113835","https://openalex.org/I28166907"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5045493438"],"corresponding_institution_ids":["https://openalex.org/I1335113835","https://openalex.org/I28166907"],"apc_list":null,"apc_paid":null,"fwci":1.1566,"has_fulltext":false,"cited_by_count":35,"citation_normalized_percentile":{"value":0.75220095,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"12","issue":"6","first_page":"724","last_page":"733"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nk-cell-inhibitory-receptors","display_name":"NK cell inhibitory receptors","score":0.8690000176429749},{"id":"https://openalex.org/keywords/kir2dl1","display_name":"KIR2DL1","score":0.8299999833106995},{"id":"https://openalex.org/keywords/kir2dl2","display_name":"KIR2DL2","score":0.8809999823570251},{"id":"https://openalex.org/keywords/kir2dl3","display_name":"KIR2DL3","score":0.9980000257492065},{"id":"https://openalex.org/keywords/kir2ds1","display_name":"KIR2DS1","score":0.9890000224113464},{"id":"https://openalex.org/keywords/kir2ds2","display_name":"KIR2DS2","score":0.9980000257492065},{"id":"https://openalex.org/keywords/nk-cell-activation","display_name":"NK cell activation","score":0.8870000243186951},{"id":"https://openalex.org/keywords/nk-cell-cytotoxicity","display_name":"NK cell cytotoxicity","score":0.746999979019165},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9670000076293945},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":1.0},{"id":"https://openalex.org/keywords/hematologic-malignancies","display_name":"hematologic malignancies","score":0.9789999723434448}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5272870659828186},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.47851812839508057},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.45432981848716736},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.44959959387779236},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4455745220184326},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.44188326597213745},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.43340036273002625},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4082673192024231},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.16349121928215027}],"mesh":[{"descriptor_ui":"D000208","descriptor_name":"Acute Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007694","descriptor_name":"Killer Cells, Natural","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D007694","descriptor_name":"Killer Cells, Natural","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D007694","descriptor_name":"Killer Cells, Natural","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D007951","descriptor_name":"Leukemia, Myeloid","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D007951","descriptor_name":"Leukemia, Myeloid","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D007951","descriptor_name":"Leukemia, Myeloid","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011485","descriptor_name":"Protein Binding","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054340","descriptor_name":"Receptors, KIR","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D055607","descriptor_name":"Receptors, Natural Killer Cell","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D055607","descriptor_name":"Receptors, Natural Killer Cell","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:21154164","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21154164","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current opinion in molecular therapeutics","raw_type":"Journal Article"},{"id":"mag:32933433","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21154164","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":4,"referenced_works":["https://openalex.org/W2120940824","https://openalex.org/W1997449608","https://openalex.org/W2763706173","https://openalex.org/W2106171217"],"related_works":["https://openalex.org/W2593329459","https://openalex.org/W2489559926","https://openalex.org/W2577603394","https://openalex.org/W2591239798","https://openalex.org/W2300424973","https://openalex.org/W2090083883","https://openalex.org/W2018580749","https://openalex.org/W2552104677","https://openalex.org/W1995224930","https://openalex.org/W2980193795"],"abstract_inverted_index":{"NK-cell":[0,23,176],"activity":[1,177],"against":[2],"tumor":[3,32],"cells":[4,127],"is":[5,54],"regulated":[6],"by":[7,19,51,178],"a":[8,55,133,174,182],"complex":[9],"balance":[10,44],"of":[11,22,37,67,97,125,140,188],"inhibitory":[12,28,39],"and":[13,27,76,89,91,93,95,119,130,164],"activating":[14,26],"signals,":[15],"which":[16],"are":[17,168],"mediated":[18],"the":[20,35,38,43,65,138,186],"binding":[21],"receptors":[24],"to":[25,45,86,102,105,148,153,170],"ligands":[29],"expressed":[30],"on":[31],"cells.":[33],"Thus,":[34],"disruption":[36],"cascade":[40],"would":[41],"shift":[42],"activation.":[46],"IPH-2101":[47,83,103,131,156,158,179],"(1-7F9),":[48],"being":[49],"developed":[50],"Innate":[52],"Pharma,":[53],"fully":[56],"human":[57],"IgG4":[58],"anti-killer":[59],"immunoglobulin-like":[60],"receptor":[61],"(KIR)":[62],"mAb":[63],"for":[64],"treatment":[66,187],"hematological":[68,189],"malignancies,":[69],"such":[70],"as":[71],"acute":[72],"myeloid":[73],"leukemia":[74],"(AML)":[75],"multiple":[77],"myeloma":[78],"(MM).":[79],"In":[80,110],"preclinical":[81],"studies,":[82],"selectively":[84],"bound":[85],"KIR2DL1,":[87],"2":[88],"3,":[90],"KIR2DS1":[92],"2,":[94],"exposure":[96],"KIR-transfected":[98],"target":[99],"cell":[100],"lines":[101],"led":[104],"an":[106],"augmented":[107],"NK-cell-mediated":[108],"lysis.":[109],"phase":[111,149],"I":[112],"clinical":[113,151],"trials":[114,152,167],"in":[115,159,185],"patients":[116,142],"with":[117,122,143,161],"AML":[118],"MM":[120,144],"treated":[121],"IPH-2101,":[123],"activation":[124],"NK":[126],"was":[128],"observed":[129],"exhibited":[132],"good":[134],"safety":[135],"profile.":[136],"At":[137],"time":[139],"publication,":[141],"had":[145],"been":[146],"recruited":[147],"II":[150],"assess":[154],"single-agent":[155],"or":[157],"combination":[160],"lenalidomide.":[162],"These":[163],"larger,":[165],"randomized":[166],"warranted":[169],"clarify":[171],"whether":[172],"enhancing":[173],"patient's":[175],"will":[180],"be":[181],"viable":[183],"approach":[184],"malignancies.":[190]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W32933433","counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
